FWP
MAZE

Falcon Wealth Planning’s Maze Therapeutics MAZE Stock Holding History

Falcon Wealth Planning’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Sell
9,630
-9
-0.1% -$236 0.02% 195
2026
Q1 		$288K Sell
9,639
-391
-4% -$17.3K 0.02% 187
2025
Q4 		$416K Buy
+10,030
New +$345K 0.04% 135

Other funds holding MAZE

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Falcon Wealth Planning's MAZE Position: Q2 2026 in Review

Falcon Wealth Planning reduced its Maze Therapeutics (MAZE) stake by 0.09% in Q2 2026, selling an estimated $236 and leaving 9,630 shares worth $287K. The position accounts for 0.02% of the portfolio, ranked #195.

Falcon Wealth Planning first reported a position in MAZE in Q4 2025 and has held it in 3 quarters since. The position peaked at $416K in Q4 2025. 7 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Falcon Wealth Planning held 9,630 shares of Maze Therapeutics worth $287K as of Q2 2026.
  • Falcon Wealth Planning sold 9 Maze Therapeutics shares in Q2 2026, an estimated $236.
  • Maze Therapeutics made up 0.02% of Falcon Wealth Planning's portfolio in Q2 2026, its #195 holding.
  • Falcon Wealth Planning first reported a position in Maze Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Falcon Wealth Planning's Maze Therapeutics position peaked at $416K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Falcon Wealth Planning's 13F filing for Q2 2026, filed 13 Jul 2026.